Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alloy vs GoodRx (Foundayo + Zepbound KwikPen)

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.4

Alloy

Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory
★★★3.7

Starting at $80/mo

Brand WegovyBrand ZepboundCompounded SemaglutideCompounded Tirzepatide
Visit Alloy
8.4

GoodRx (Foundayo + Zepbound KwikPen)

Best for self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies
★★★★4.2

Starting at $149/mo

FoundayoZepbound KwikPenBrandSelf-Pay Discount Card
Visit GoodRx (Foundayo + Zepbound KwikPen)

Side-by-Side Comparison

FeatureAlloyGoodRx (Foundayo + Zepbound KwikPen)
Overall Score7.4/108.4/10
Starting Price$80/mo$149/mo
Editorial Rating3.7 ★ /54.2 ★ /5
Features8 features6 features
States Available050
Compounded✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alloy

Pros

  • Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
  • All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
  • Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
  • STARTGLP1 promo code knocks $50 off the first month per the public site

Cons

  • Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
  • Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
  • Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss

GoodRx (Foundayo + Zepbound KwikPen)

Pros

  • $149/month self-pay price for FDA-approved brand-name Foundayo (orforglipron) — matches the lowest available discounted cash price at launch and is dramatically cheaper than typical retail brand-GLP-1 pricing
  • $299/month self-pay for FDA-approved Zepbound KwikPen — significantly under the typical Lilly cash list price
  • Honored at 70,000+ US pharmacies nationwide — by far the largest brick-and-mortar redemption network of any GLP-1 distribution channel we cover
  • No telehealth membership fee — you bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded — no compounding-pharmacy quality variability or FDA non-evaluation disclaimer
  • Pharmaceutical manufacturer-direct pricing model — Lilly is delivering the discounted cash price directly through GoodRx, not a third-party negotiation

Cons

  • Requires a valid prescription — GoodRx is a discount card, not a telehealth provider. You still need a clinician to write the script (your existing PCP, an endocrinologist, or a separate telehealth visit)
  • Self-pay only — does not coordinate with insurance benefits or apply toward insurance deductibles
  • Pricing applies only to the lowest Foundayo dose at the headline number; higher doses may carry different pricing not disclosed in the launch
  • Does not include compounded GLP-1s — if you want compounded semaglutide or tirzepatide, this is not the channel
  • GoodRx is publicly traded (NASDAQ: GDRX) and pricing is subject to change as Lilly's manufacturer-sponsored coupon program evolves

Our Verdict

Winner: GoodRx (Foundayo + Zepbound KwikPen)Score: 8.4/10

GoodRx (Foundayo + Zepbound KwikPen) edges out Alloy with a higher overall score of 8.4/10 and is particularly strong for self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies. Alloy remains a solid alternative, especially if you're looking for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.